Medical News

RSS

Pediatric and adolescent patients who receive antipsychotic medications experience weight gain

Many pediatric and adolescent patients who received second-generation antipsychotic medications experienced significant weight gain, along with varied adverse effects on cholesterol and triglyceride levels and other metabolic measures, according to a study in the October 28 issue of JAMA.

28 Oct 2009

Recruitment of Phase II trial of TB-402 completed ahead of schedule

ThromboGenics NV and co-development partner BioInvent International announce that they have completed recruitment of their Phase II trial of TB-402 ahead of schedule.

28 Oct 2009

VHA helps nurses to develop work processes that are more patient-centric

Nurses work in a world of broken systems, wasted time and energy, which can be incredibly frustrating and detrimental to patient care. Most national studies show that nurses spend as little as 30 percent of their day engaged in direct patient care activities, and this can contribute to poor patient outcomes in terms of infections and other complications, poor patient and nurse satisfaction and poor quality of care overall.

28 Oct 2009

Overseas and domestically adopted children have similar disability rates, says study

Children adopted from overseas have disability rates similar to those adopted from within the United States, according to new research from the University of North Carolina at Chapel Hill.

28 Oct 2009

Megadyne enters into one-year partnership with Attainia

Megadyne, an end-to-end, full-solution electrosurgical equipment and accessory developer/manufacturer, announced today that it has entered into a one-year partnership with Attainia, an industry-leading online marketplace for medical capital equipment.

28 Oct 2009

PPD signs agreement to invest $100 million in Celtic Therapeutics Holdings

PPD, Inc. today announced it has signed an agreement to invest $100 million in Celtic Therapeutics Holdings L.P., an investment partnership organized for the purpose of identifying, acquiring and investing in a diversified portfolio of 10 to 15 novel therapeutic product candidates.

28 Oct 2009

DiabetEZE, an energy bar designed and developed for diabetics launched

Innova Nutrition announced today the launch of "DiabetEZE," an energy bar designed and developed for diabetics, but great for everyone.

28 Oct 2009

Manhattan Scientifics and Senior Scientific team up to commercialize cancer detection technology

Manhattan Scientifics (OTCBB: MHTX) and Senior Scientific, LLC announced today that they have begun cooperative work to commercialize Senior Scientific’s nano medicine cancer detection technology.

28 Oct 2009

Multidisciplinary center to be launched for treatment of advanced liver disease

Distinguished transplant and cancer surgeon, Alan Hemming, MD, has been recruited to the University of California, School of Medicine to launch a multidisciplinary center for the treatment of advanced liver disease at the UC San Diego Medical Center and Moores UCSD Cancer Center.

28 Oct 2009

Renowned surgeons to discuss latest advances in laparoscopic surgery at upcoming MISS meeting

The upcoming prestigious Minimally Invasive Surgery Symposium (MISS) will include discussion of advances in metabolic surgery, a robotic approach to colon surgery, single-port bariatric surgery, transoral gastroplasty, and other "frontier" topics.

28 Oct 2009

Experts release policy recommendations to promote better medication adherence and health outcomes

A diverse group of health care and consumer organizations released five policy recommendations this week that are designed to promote better medication adherence and improved health outcomes for patients.

28 Oct 2009

Clinical results of INVO procedure for treatment of infertility announced

INVO Bioscience announced that CECOLFES (http://cecolfes.com/), Colombia Fertility Center, Bogota, Colombia, the first center in Latin America to introduce the INVOcell device and the INVO procedure for treatment of infertility, made known today the results of the first 28 cycles of the INVO procedure.

28 Oct 2009

EPA's guide provides vital information on child’s exposure to pollutants

The U.S. Environmental Protection Agency today released a user-friendly document to help risk assessors understand how children are exposed to pollution.

28 Oct 2009

Medtronic announces the international launch of PoleStar N30 Surgical MRI system

This week at the annual Congress of Neurological Surgeons (CNS), Medtronic (NYSE: MDT) announced the Conformite Europeen (CE) mark and international launch of the PoleStar® N30 Surgical MRI system, the latest in neuro oncology surgical solutions.

28 Oct 2009

Research experts to discuss best practices for research and development investments

Research management experts from across federal science agencies will gather in Washington, D.C., Oct. 28-29, to discuss approaches for identifying research priorities, exploring research performance management, and assessing the impact of completed research.

28 Oct 2009

Researchers find link between foreskin and HIV infection

Randomized clinical trials conducted by researchers in Rakai, Uganda, have revealed a link between the size of foreskin surface area and the risk of male HIV acquisition.

28 Oct 2009

Addus HomeCare announces pricing of initial public offering; grants option to purchase additional 810,000 shares

Addus HomeCare Corporation announced today that it has priced the initial public offering of 5,400,000 shares of its common stock at $10.00 per share. Addus shares will begin trading on October 28, 2009 on the Nasdaq Global Market under the ticker symbol "ADUS".

28 Oct 2009

FDA issues clearance for Lumenis' PolyScope Flexible Endoscope

Lumenis Ltd., a global developer, manufacturer and seller of laser, light-based and radiofrequency devices for surgical, aesthetic, and ophthalmic applications, announced that on September 30th, 2009 the FDA issued a 510K to Lumenis stating that the PolyScope Flexible Endoscope can now be sold in the United States.

From Lumenis Inc. 28 Oct 2009

Toxic chemicals in face paints can cause skin sensitization and contact dermatitis

Ghosts and goblins aren't the only spooky things lurking around this Halloween. A new report by the Campaign for Safe Cosmetics reveals that popular children's face paints contain lead, a potent neurotoxin, as well as nickel, cobalt and chromium, which can cause lifelong skin sensitization and contact dermatitis.

28 Oct 2009

POZEN announces Phase I study results of PA65020

POZEN Inc. announced today the results of a Phase I study that showed a novel, investigational combination of enteric-coated aspirin (EC-ASA) and immediate-release omeprazole known as PA65020, is associated with a significantly decreased risk of GI mucosal damage compared to analgesic doses (650 mg twice daily) of over-the-counter enteric-coated aspirin (EC-ASA) in healthy adults treated for one month.

28 Oct 2009

Medical News

Pediatric and adolescent patients who receive antipsychotic medications experience weight gain

Recruitment of Phase II trial of TB-402 completed ahead of schedule

VHA helps nurses to develop work processes that are more patient-centric

Overseas and domestically adopted children have similar disability rates, says study

Megadyne enters into one-year partnership with Attainia

PPD signs agreement to invest $100 million in Celtic Therapeutics Holdings

DiabetEZE, an energy bar designed and developed for diabetics launched

Manhattan Scientifics and Senior Scientific team up to commercialize cancer detection technology

Multidisciplinary center to be launched for treatment of advanced liver disease

Renowned surgeons to discuss latest advances in laparoscopic surgery at upcoming MISS meeting

Experts release policy recommendations to promote better medication adherence and health outcomes

Clinical results of INVO procedure for treatment of infertility announced

EPA's guide provides vital information on child’s exposure to pollutants

Medtronic announces the international launch of PoleStar N30 Surgical MRI system

Research experts to discuss best practices for research and development investments

Researchers find link between foreskin and HIV infection

Addus HomeCare announces pricing of initial public offering; grants option to purchase additional 810,000 shares

FDA issues clearance for Lumenis' PolyScope Flexible Endoscope

Toxic chemicals in face paints can cause skin sensitization and contact dermatitis

POZEN announces Phase I study results of PA65020

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Latest News